A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
Open Access
- 1 April 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (2), 182-189
- https://doi.org/10.1215/15228517-2007-053
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Hopkins Verbal Learning Test – Revised: Normative Data and Analysis of Inter-Form and Test-Retest ReliabilityThe Clinical Neuropsychologist, 1998
- Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use (1997)Journal of Immunotherapy, 1997
- Stereotactic radiosurgery for glioblastoma: a final report of 31 patientsJournal of Neurosurgery, 1995
- Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary reportJournal of Neuro-Oncology, 1995
- Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomasCancer, 1994
- Supratentorial malignant glioma: Patterns of recurrence and implications for external beam local treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Results of Stereotactic Brachytherapy Used in the Initial Management of Patients With GlioblastomaJNCI Journal of the National Cancer Institute, 1990
- The Localisation of Radiolabeled Murine Monoclonal Antibody 81C6 and its Fab Fragment in Human Glioma Xenografts in Athymic MiceBritish Journal Of Neurosurgery, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958